Dr. Nataliya Ternopolska, MD

Dr. Ternopolska practices at St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania.

Dr. Ternopolska's NPI, 1093943896, was assigned on June 30, 2009. Dr. Ternopolska holds Pennsylvania license MD451738.

Dr. Ternopolska's primary practice is St Lukes University Hospital Bethlehem, at 801 Ostrum St, Bethlehem, PA 18015 in Northampton County. The practice phone is (610) 954-4000.

Dr. Ternopolska's primary practice is St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania. Dr. Ternopolska is also affiliated with St. Luke's University Hospital - Bethlehem Campus. The medical group on file is St. Luke's South Mountain Family Practice. Dmand AI also links Dr. Ternopolska to 5 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ternopolska practices, 9 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Ternopolska's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Ternopolska's licenses on file in 2 states: Pennsylvania and New York.

CMS data shows 442 Medicare services from Dr. Ternopolska across 9 procedure codes in 2024, for 283 Medicare patients. Medicare paid $32,285 for them.

CMS counts 283 Medicare patients who saw Dr. Ternopolska in 2024. The largest group is 65 to 74, with 116 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ternopolska's median patient age at 62, with 68% women.

In 2024, Dr. Ternopolska wrote 1,461 Medicare Part D claims for 222 patients. 76% of them were for generic drugs. CMS names the drug for 1,251 of them, across 43 drugs with 11 or more claims each, at $2,308,038 in total drug cost. In 2023, CMS named 1,429 claims across 47 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Ternopolska for performance year 2024, reported through an alternative payment model (APM). Dr. Ternopolska accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ternopolska as offering telehealth.

Dmand AI links 1 paper to Dr. Ternopolska in 2015. Dr. Ternopolska's most frequent co-authors are Suchit K. Bhutani, MD, Margot Boigon, MD and David Gary Smith, MD.

CMS Open Payments shows 115 general payments to Dr. Ternopolska from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Biogen, Inc. paid the most, $883.